We are live on ! Find out more
XERS icon

Xeris Biopharma Holdings
XERS

92 hedge funds and large institutions have $120M invested in Xeris Biopharma Holdings in 2021 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 33 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more call options, than puts

Call options by funds: $6.72M | Put options by funds: $1.92M

230% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 10

180% more capital invested

Capital invested by funds: $42.9M → $120M (+$77.3M)

120% more repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 15

31% more funds holding

Funds holding: 70 → 92 (+22)

6.58% more ownership

Funds ownership: 26.34% → 32.91% (+6.6%)

Holders
92
Holders Change
+22
Holders Change %
+31.43%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.03%
New
33
Increased
33
Reduced
15
Closed
10
Calls
$6.72M
Puts
$1.92M
Net Calls
+$4.8M
Net Calls Change
+$736K

Top Buyers

Rank Fund Capital Flow
1
CC
Caxton Corporation
New Jersey
+$13.6M
2
SCM
Stonepine Capital Management
Oregon
+$12.2M
3
NMC
NEA Management Company
Maryland
+$7.02M
4
Lazard Asset Management
Lazard Asset Management
New York
+$5.03M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$4.62M

Top Sellers

Rank Fund Capital Flow
1
SC
Sessa Capital
New York
-$8.97M
2
RG
Redmile Group
California
-$674K
3
BCM
Bridgeway Capital Management
Texas
-$346K
4
SFI
Susquehanna Fundamental Investments
Pennsylvania
-$190K
5
AGM
Alpine Global Management
New York
-$162K
Name Holding Trade Value Shares
Change 		Change in
Stake
Commonwealth Equity Services
26
Commonwealth Equity Services
Massachusetts
$577K +$215K +99,650 +102%
Northern Trust
27
Northern Trust
Illinois
$557K +$145K +67,263 +55%
SFI
28
Susquehanna Fundamental Investments
Pennsylvania
$547K -$190K -87,816 -32%
DT
29
Diversified Trust
Tennessee
$456K +$336K +155,650 New
FFH
30
Fairfax Financial Holdings
Ontario, Canada
$441K +$327K +151,395 New
6CM
31
683 Capital Management
New York
$356K +$197K +91,367 +305%
Qube Research & Technologies (QRT)
32
Qube Research & Technologies (QRT)
United Kingdom
$356K +$263K +121,627 New
Citadel Advisors
33
Citadel Advisors
Florida
$335K +$83.2K +38,513 +51%
Jane Street
34
Jane Street
New York
$332K +$211K +97,476 +612%
GCP
35
GSA Capital Partners
United Kingdom
$326K +$240K +111,272 New
AC
36
Aristides Capital
Kentucky
$293K +$216K +100,080 New
Bank of New York Mellon
37
Bank of New York Mellon
New York
$281K +$88K +40,725 +74%
CAN
38
Cetera Advisor Networks
California
$250K +$184K +85,375 New
CL
39
CSS LLC
Illinois
$205K +$151K +69,834 New
Dimensional Fund Advisors
40
Dimensional Fund Advisors
Texas
$204K +$46.2K +21,402 +44%
Charles Schwab
41
Charles Schwab
California
$197K +$96.2K +44,532 +198%
PPA
42
Parametric Portfolio Associates
Washington
$191K +$141K +65,090 New
KSCM
43
Kamunting Street Capital Management
Florida
$189K +$139K +64,539 New
AWM
44
AE Wealth Management
Kansas
$175K +$29.4K +13,588 +29%
GWSG
45
GPS Wealth Strategies Group
Colorado
$173K +$2.16K +1,000 +2%
Ameriprise
46
Ameriprise
Minnesota
$168K +$5.19K +2,401 +5%
Chevy Chase Trust
47
Chevy Chase Trust
Maryland
$150K – – –
IC
48
IEQ Capital
California
$147K +$108K +50,169 New
FIA
49
FNY Investment Advisers
New York
$143K +$106K +49,088 New
CM
50
Caption Management
Oklahoma
$140K +$103K +47,600 New
1
2
3 4

XERS Hedge Fund Activity: Q4 2021 in Review

92 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Xeris Biopharma Holdings (XERS) for Q4 2021, worth a combined $120M — up 180% from $42.9M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new XERS positions and 10 closed out — a net gain of 23 holders — while 33 added to existing stakes and 15 trimmed.

The largest buyer was Caxton Corporation, opening a new position worth an estimated $13.6M. The largest seller was Sessa Capital, exiting entirely with an estimated $8.97M sold.

  • 92 institutional investors held Xeris Biopharma Holdings (XERS) as of Q4 2021, up from 70 in Q3 2021.
  • Funds reported $120M of Xeris Biopharma Holdings stock for Q4 2021, up 180% quarter-over-quarter.
  • 33 funds opened new Xeris Biopharma Holdings positions in Q4 2021 and 10 closed out, a net change of +23 holders.
  • The largest Xeris Biopharma Holdings buyer in Q4 2021 was Caxton Corporation, an estimated $13.6M added.
  • The largest Xeris Biopharma Holdings seller in Q4 2021 was Sessa Capital, an estimated $8.97M sold.

Based on aggregated 13F filings for Q4 2021.